APA (7e ed.) Bronvermelding

Bidmos, F., Nadel, S., Screaton, G., Kroll, J., & Langford, P. (2018). Cross-reactive bactericidal antimeningococcal antibodies can be isolated from convalescing invasive meningococcal disease patients using reverse vaccinology 2.0. Frontiers Research Foundation.

Chicago (17e ed.) Bronvermelding

Bidmos, F., S. Nadel, G. Screaton, J. Kroll, en P. Langford. Cross-reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated from Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers Research Foundation, 2018.

MLA (9e ed.) Bronvermelding

Bidmos, F., et al. Cross-reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated from Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers Research Foundation, 2018.